Baird Maintains Outperform on Boston Scientific, Raises Price Target to $91
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott maintains an Outperform rating on Boston Scientific (NYSE:BSX) and raises the price target from $90 to $91.
July 25, 2024 | 11:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst David Rescott maintains an Outperform rating on Boston Scientific and raises the price target from $90 to $91.
The Outperform rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100